Spinal Tech

Technological advancements and the rise in minimally invasive surgery cases will spur the spine biologics market growth.

Here are eight devices that were recently launched or released.

Intellirod Spine has secured more than $1 million in additional equity financing from new and existing investors.

Medtronic invested in Mazor and the robotic spine technology’s new product, Mazor X. However, the robot is still expensive for providers in a value-based world. In a Seeking Alpha report, Avinash Menon discusses the shift toward features-based pricing.

CMS released Open Payments data for 2015 showing that healthcare industry manufacturers and companies reported $7.52 billion in payments as well as ownership and investment interests to physicians and teaching hospitals. 

Wall Street analysts anticipate NuVasive will report earnings per share of $0.47, according to Investor Newswire.

The global medical robotics market is positioned to hit $17.9 billion by 2022.

Medtronic launched VariLoc Locking Compression Plate System in China, as well as a few other countries.

The Food and Drug Administration granted 31 orthopedic- and spine-related device clearances in June.

Pan Medical has just launched the InterV Micro.